INSULET CORP
Develops and markets tubeless, wearable insulin delivery systems for diabetes.
PODD | US
Overview
Corporate Details
- ISIN(s):
- US45784P1012
- LEI:
- Country:
- United States of America
- Address:
- 100 NAGOG PARK, 1720 ACTON
- Website:
- https://www.omnipod.com
- Sector:
- Manufacturing
Description
Insulet Corporation is a medical device company that develops, manufactures, and markets innovative technologies for people with diabetes. The company's core product is the Omnipod® platform, which provides a tubeless and wearable alternative to traditional insulin pumps and multiple daily injections. The flagship product, the Omnipod 5 Automated Insulin Delivery System, is a hybrid closed-loop system that integrates with compatible continuous glucose monitors (CGMs). It utilizes SmartAdjust™ technology to automatically predict glucose levels and adjust insulin delivery to help manage glucose levels. The platform also includes the Omnipod DASH® Insulin Management System. Insulet's products are designed to offer simplicity and freedom for individuals with type 1 and type 2 diabetes who require insulin therapy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all INSULET CORP filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for INSULET CORP
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for INSULET CORP via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
